HARMONY is a European network of excellence that captures, integrates, analyzes, and harmonizes big data from high-quality multidisciplinary sources with the purpose to unlock valuable knowledge on various important hematologic malignancies (HMs). With this, a more rapid detection of promising treatment strategies and adverse events will be made possible, while taking into account demographic changes, individual patients’ needs, as well as the need to define standard outcome measures for the HMs to be included HARMONY. By bringing together key stakeholders in the clinical, academic, patient, HTA (health technology assessment), regulatory, economical, ethical and pharmaceutical field HARMONY will: (i) rapidly capture the current status in treating HMs; (ii) define the areas of utmost need for improved patient management; (iii) redefine the treatment goals based in individualized risk assessments and outcome measures; (iv) aim at better characterizing HMs for improved treatment strategies; (v) identify novel treatment targets and drugs; (vi) foster the design, management and coordination of innovative clinical and pre-clinical studies; (vii) raise awareness of cost-effectiveness by pursuing precision medicine approaches; (viii) provide novel resources and algorithms to more rapidly advance innovative concepts of health care and patient management in the field of HMs.

Publikace